Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use DARIFENACIN extended-release tablets safely and effectively. See full prescribing information for DARIFENACIN extended-release tablets. DARIFENACIN extended-release tablets Initial U.S. Approval: 2004
Medication labelWhy this: Advisory · dailymed-prescription
Darifenacin extended-release tablets are a muscarinic antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency and frequency.
- generic_name
- darifenacin hydrobromide
- product_names
- darifenacin hydrobromide
- ndc
- 70754-161, 70754-161-03, 70754-161-50, 70754-162, 70754-162-03, 70754-162-50
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en